RecruitingNCT06559826
Ketamine-assisted psychotherapy or ketamine alone for depression
About this title
Read the official source — NCT06559826Medication studyAges 18–90United States
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 90 years. Other eligibility criteria apply.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 10, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 70
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 90 Years
- Official registry ID
- NCT06559826
- Official title
Show the full official title
A Randomized-Controlled Trial of Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Icahn School of Medicine at Mount Sinai, a university.
Does this study involve medication?
Yes. The study involves medication, including ketamine.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 90 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
